|
End-of-day quote
Amman S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 1.930 JOD | +4.89% |
|
-2.53% | +20.62% |
| 07-21 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
Stock exchange
Amman S.E.
PHIL 1.930 JOD
+4.89%
19.3
JOD
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| PHIL | 1.930JOD | +4.89% | 19.3 JOD |
Quotes 5-day view: Philadelphia Pharmaceuticals Company
End-of-day quote Amman S.E.| 2026-08-20 | 2026-08-23 | Today | |
|---|---|---|---|
| Last | JOD 1.840 | JOD 1.840 | JOD 1.930 |
| Volume | 371 | 229 | 10 |
| Change | - | 0.00% | +4.89% |
| Opening | JOD 1.870 | JOD 1.840 | JOD 1.930 |
| High | JOD 1.870 | JOD 1.840 | JOD 1.930 |
| Low | JOD 1.840 | JOD 1.840 | JOD 1.930 |
Performance
| 1 day | +4.89% | ||
| 1 week | -2.53% | ||
| Current month | -3.50% | ||
| 1 month | -3.50% | ||
| 3 months | +12.21% | ||
| 6 months | +24.52% | ||
| Current year | +20.62% | ||
| 1 year | +32.19% | ||
| 3 years | +35.92% | ||
| 5 years | +39.86% | ||
| 10 years | -36.72% |
Volumes
marketsDaily volume
10
Avg. Volume 20 sessions
720
Avg. Volume 20 sessions JOD
1,389.6
Avg. Volume 20 sessions USD
1,962.71
Record volume 1
2,992,594
Record volume 2
2,211,594
Record volume 3
1,536,403
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (JOD)
13,804,869
Market Cap (USD)
19,477,770
Net sales ()
9,169,000
Net sales (USD)
12,936,861
Number of employees
129
Sales / Employee (JOD)
71,078
Sales / Employee (USD)
100,286
Free-Float
7.27 %
Free-Float capitalization (JOD)
1,003,614
Free-Float capitalization (USD)
1,416,034
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
1.91
Moving average 20 days
1.86
Moving average 50 days
1.67
Moving average 100 days
1.56
Price spread / (MMA5)
-1.04%
Price spread / (MMA20)
-3.63%
Price spread / (MMA50)
-13.47%
Price spread / (MMA100)
-19.17%
RSI 9 days
57.99
RSI 14 days
61.16
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.89% | -2.53% | +32.19% | +35.92% | 19.48M | |
| +0.40% | -1.04% | +16.34% | +69.97% | 47.71B | |
| +0.12% | +1.50% | +51.38% | +122.20% | 40.3B | |
| +0.40% | -0.83% | -9.73% | +16.84% | 12.09B | |
| -1.45% | -2.77% | +11.63% | +71.04% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +158.71% | 9.19B | |
| +3.49% | +2.54% | +24.70% | +43.56% | 7.57B | |
| -0.16% | +0.58% | +47.14% | -11.83% | 7.24B | |
| +3.14% | +3.12% | +23.40% | +215.25% | 6.84B | |
| -3.24% | -9.40% | -40.05% | +18.52% | 5.42B | |
| Average | +0.75% | -1.47% | +18.80% | +74.02% | 14.81B | |
| Weighted average by Cap. | +0.27% | -0.65% | +24.48% | +84.92% |
Historical Quotes: Philadelphia Pharmaceuticals Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1.84 |  | 1.93 |
| 1 month | 1.84 | | 2.01 |
| Current year | 1.5 | | 2.01 |
| 1 year | 1.48 | | 2.01 |
| 3 years | 1.36 | | 2.01 |
| 5 years | 1.28 | | 2.01 |
| 10 years | 1.28 | | 3.19 |
Monthly variations
Annual variations
| 2026 | +20.63% | ||
| 2025 | +6.67% | ||
| 2024 | +4.90% | ||
| 2023 | +2.88% | ||
| 2022 | +1.46% | ||
| 2021 | -4.20% | ||
| 2020 | -8.33% | ||
| 2019 | -1.27% | ||
| 2018 | +1.94% | ||
| 2017 | -29.86% | ||
| 2016 | -27.30% | ||
| 2015 | -6.06% | ||
| 2014 | +405.63% | ||
| 2013 | +153.97% | ||
| 2012 | -20.25% | ||
| 2011 | -16.84% | ||
| 2010 | -45.40% |
- Stock Market
- Stocks
- PHIL Stock
- Quotes Philadelphia Pharmaceuticals Company
Select your edition
All financial news and data tailored to specific country editions
